The synergistic interplay between vitamin A, dietary fiber, and the microbiota-gut-brain axis: a potential mechanism for preventing Alzheimer’s disease
American Journal of Physiology-Gastrointestinal and Liver Physiology · 2025
DOI: 10.1152/ajpgi.00097.2025 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, 2025. Verfasst von Shadt Skawratananond und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, Texas, United States. Hauptthemen laut MEDLINE: Alzheimer Disease, Gastrointestinal Microbiome, Dietary Fiber, Vitamin A. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 170 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, HHS | NIH | National Institute on Aging (NIA), Texas Tech University Health Sciences Center (TTUHSC).
Themen: Demenz
Abstract (Originalsprache)
The human gastrointestinal tract harbors a vast and diverse microbial community, with the gut microbiome playing a fundamental role in numerous biological processes that influence overall health and disease progression. Emerging evidence has identified bacterial lipopolysaccharides in the hippocampus of patients with Alzheimer’s disease (AD), highlighting the intricate relationship between the gastrointestinal tract, gut microbiome, and the central and enteric nervous systems—commonly referred to as the “microbiota-gut-brain axis.” In this review, we explore the mechanisms by which the microbiota-gut-brain axis contributes to AD pathogenesis. We propose that sufficient levels of all-trans retinoic acid (ATRA), the bioactive form of vitamin A, enhance intestinal barrier integrity by upregulating tight junction proteins and modulating immune function through the induction of regulatory T-cell differentiation, thereby mitigating inflammation. Furthermore, dietary fiber complements this process by promoting the production of short-chain fatty acids, such as butyrate, via bacterial fermentation. Butyrate, in turn, acts as a histone deacetylase inhibitor, upregulating ATRA bioavailability by elevating aldehyde dehydrogenase gene expression. Our mechanistic framework is supported by the endotoxin hypothesis of AD, which maintains that the movement of infectious pathogens across the blood-brain barrier causes a vicious cycle of inflammation, a key factor of AD pathogenesis, leading to amyloid-β deposition, microglial activation, and CYP26A1-mediated ATRA degradation. Finally, we discuss microbiome-based therapeutic strategies and dietary interventions, including prebiotic compounds, probiotic bacteria, fecal microbiota transplantation, the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet, and a combined approach featuring vitamins A/D and dietary fiber, as potential approaches to prevent progression to AD via the microbiota-gut-brain axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, Texas, United States.
- School of Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, United States.
- Garrison Institute on Aging, Texas Tech University Health Sciences Center, Lubbock, Texas, United States.
- Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center, Lubbock, Texas, United States.
- Honors College, Texas Tech University, Lubbock, Texas, United States.
- Center of Excellence for Translational Neuroscience and Therapeutics, Texas Tech University Health Sciences Center, Lubbock, Texas, United States.
ORCID-Profile: Shadt Skawratananond, Paul Lie, Shane C Smith, Charlie Zhang, Aric F Logsdon, J Josh Lawrence
Förderung
- NIA NIH HHS
- HHS | NIH | National Institute on Aging (NIA)
- Texas Tech University Health Sciences Center (TTUHSC)
Zitieren
APA
Skawratananond, S., McCrea, G. E., Lie, P., Buxton, M. B., Daly, S. P., Vojtkofsky, N. A., Smith, S. C., Zhang, C., Hernandez, M., Hindle, A., Logsdon, A. F., & Lawrence, J. J. (2025). The synergistic interplay between vitamin A, dietary fiber, and the microbiota-gut-brain axis: a potential mechanism for preventing Alzheimer’s disease. American Journal of Physiology-Gastrointestinal and Liver Physiology. https://doi.org/10.1152/ajpgi.00097.2025
Vancouver
Skawratananond S, McCrea GE, Lie P, Buxton MB, Daly SP, Vojtkofsky NA, et al. The synergistic interplay between vitamin A, dietary fiber, and the microbiota-gut-brain axis: a potential mechanism for preventing Alzheimer’s disease. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2025. doi:10.1152/ajpgi.00097.2025
BibTeX
@article{Skawratananond2025,
author = {Skawratananond, Shadt and McCrea, Grace E and Lie, Paul and Buxton, Matthew B and Daly, Sean P and Vojtkofsky, Nicholas A and Smith, Shane C and Zhang, Charlie and Hernandez, Matthew and Hindle, Ashly and Logsdon, Aric F and Lawrence, J Josh},
title = {The synergistic interplay between vitamin A, dietary fiber, and the microbiota-gut-brain axis: a potential mechanism for preventing Alzheimer’s disease},
journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
year = {2025},
doi = {10.1152/ajpgi.00097.2025}
}
EUVIMED